At LogiPharma USA 2026, the keynote panel on building a truly end-to-end supply chain centered on a familiar industry problem ...

Global Benchmark for Efficient Drug Pricing (GLOBE) Model, CMS's most favored nation (MFN) pricing policy for Medicare Part B ...

According to Nitin Jayakrishnan, co-founder and CEO of Freehand, disruptions that pharmaceutical supply chains once treated ...

At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains. Supply chain ...

At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation. According to Garrett Freeman, sales ...

Please check back later for more content.

McKesson's Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies. As therapies become more targeted and time-sensitive, ...

Explain why commercialization readiness begins much sooner than executives think. Identify early operational ...

AI should not be framed as influencing prescribing; it can close the information-access gap by delivering brand-approved, ...

At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance. As regulators sharpen their ...

Identify early operational decisions—product handling requirements, product configuration, transportation strategies, temperature management requirements, and supply chain design—that affect ...

Tempaid expands capability in parcel/last-mile formats, including SpeedyPac and SteadyPac lines, plus in-house R&D, ...